Works matching IS 15588211 AND DT 2022 AND VI 17 AND IP 6

Results: 14

Molecular Pathogenesis of Myeloproliferative Neoplasms.

Published in:

Current Hematologic Malignancy Reports, 2022, v. 17, n. 6, p. 319, doi. 10.1007/s11899-022-00685-1

By:

Rolles, Benjamin;
Mullally, Ann

Publication type:

Article

Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies.

Published in:

Current Hematologic Malignancy Reports, 2022, v. 17, n. 6, p. 275, doi. 10.1007/s11899-022-00684-2

By:

Atluri, Himachandana;
Gerstein, Yoheved S.;
DiNardo, Courtney D.

Publication type:

Article

CML Resistant to 2nd-Generation TKIs: Mechanisms, Next Steps, and New Directions.

Published in:

Current Hematologic Malignancy Reports, 2022, v. 17, n. 6, p. 198, doi. 10.1007/s11899-022-00683-3

By:

Scalzulli, Emilia;
Carmosino, Ida;
Bisegna, Maria Laura;
Martelli, Maurizio;
Breccia, Massimo

Publication type:

Article

The Role of Belantamab Mafodotin, Selinexor, and Melflufen in Multiple Myeloma.

Published in:

Current Hematologic Malignancy Reports, 2022, v. 17, n. 6, p. 306, doi. 10.1007/s11899-022-00682-4

By:

McCurdy, Arleigh;
Visram, Alissa

Publication type:

Article

Pediatric Germline Predisposition to Myeloid Neoplasms.

Published in:

Current Hematologic Malignancy Reports, 2022, v. 17, n. 6, p. 266, doi. 10.1007/s11899-022-00681-5

By:

Thompson, Christineil;
Ariagno, Sydney;
Kohorst, Mira A.

Publication type:

Article

Progress and Challenges in Survivorship After Acute Myeloid Leukemia in Adults.

Published in:

Current Hematologic Malignancy Reports, 2022, v. 17, n. 6, p. 243, doi. 10.1007/s11899-022-00680-6

By:

Granroth, Ginna;
Khera, Nandita;
Arana Yi, Cecilia

Publication type:

Article

Therapy Resistance and Disease Progression in CML: Mechanistic Links and Therapeutic Strategies.

Published in:

Current Hematologic Malignancy Reports, 2022, v. 17, n. 6, p. 181, doi. 10.1007/s11899-022-00679-z

By:

Ng, John Joson;
Ong, S. Tiong

Publication type:

Article

Prevalence and Determinants of Return to Work as a Patient-Centered Outcome in Survivors of Hematopoietic Cell Transplantation.

Published in:

Current Hematologic Malignancy Reports, 2022, v. 17, n. 6, p. 228, doi. 10.1007/s11899-022-00678-0

By:

Bhatt, Neel S.

Publication type:

Article

Circulating Tumor DNA in Lymphoma.

Published in:

Current Hematologic Malignancy Reports, 2022, v. 17, n. 6, p. 298, doi. 10.1007/s11899-022-00677-1

By:

Kambhampati, Swetha;
Zain, Jasmine

Publication type:

Article

Role of Germline Predisposition to Therapy-Related Myeloid Neoplasms.

Published in:

Current Hematologic Malignancy Reports, 2022, v. 17, n. 6, p. 254, doi. 10.1007/s11899-022-00676-2

By:

Baranwal, Anmol;
Hahn, Christopher N.;
Shah, Mithun Vinod;
Hiwase, Devendra K.

Publication type:

Article

Bispecific Antibodies for the Treatment of Multiple Myeloma.

Published in:

Current Hematologic Malignancy Reports, 2022, v. 17, n. 6, p. 286, doi. 10.1007/s11899-022-00675-3

By:

Goldsmith, Scott R.;
Streeter, Shawn;
Covut, Fahrettin

Publication type:

Article

Precision Medicine in Myeloid Malignancies: Hype or Hope?

Published in:

Current Hematologic Malignancy Reports, 2022, v. 17, n. 6, p. 217, doi. 10.1007/s11899-022-00674-4

By:

Upadhyay Banskota, Shristi;
Khanal, Nabin;
Marar, Rosalyn I.;
Dhakal, Prajwal;
Bhatt, Vijaya Raj

Publication type:

Article

Value in Myeloma Care: Myth or Reality.

Published in:

Current Hematologic Malignancy Reports, 2022, v. 17, n. 6, p. 206, doi. 10.1007/s11899-022-00669-1

By:

Ouchveridze, Evguenia;
Berger, Katherine;
Mohyuddin, Ghulam Rehman

Publication type:

Article

Defining Higher-Risk Chronic Myeloid Leukemia: Risk Scores, Genomic Landscape, and Prognostication.

Published in:

Current Hematologic Malignancy Reports, 2022, v. 17, n. 6, p. 171, doi. 10.1007/s11899-022-00668-2

By:

Shahrin, Nur Hezrin;
Wadham, Carol;
Branford, Susan

Publication type:

Article